This nugget has me excited:
Management are seeking to fund this project without major dilution. Whilst there may be a CR along the way, the vast majority will be funded without CR.
More back of napkin figures:
-$1.6B/pa revenue as stated in above comments
-Estimated 400m total shares on issue after CR
-Earnings per share - $4
Buy.
Ann: Scoping Study and offtake discussions commence, page-20
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)